10x Genomics, Inc. company logo
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) Cash From Investing

Annual CFI

-$32.63M$166.12M-124.44%

Summary

Current Value
As of today, TXG annual cash from investing is -$32.63M, down -124.44% on
Historical Performance
TXG annual cash from investing is up +69.43% over the past 3 years, and up +23.70% over the past 5 years
All-Time High Comparison
TXG annual cash from investing is currently -124.44% below its historical high of $133.49M set on
3-Year Low Comparison
TXG annual cash from investing is +90.70% above its 3-year low of -$350.89M reached on an earlier date
Sector Comparison
TXG annual cash from investing is higher than 26.61% of companies in Healthcare sector

Cash From Investing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TXG Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Investing-$32.63M-124.4%+69.4%+23.7%-768.8%
Quarterly Cash From Investing-$8.80M-143.3%+73.0%-571.8%
TTM Cash From Investing-$63.23M-297.2%+81.7%-178.4%
Price$19.99+28.7%-47.1%-87.4%
Annual Cash From Operations$6.66M+143.8%+131.2%-80.8%+162.3%
Annual Cash From Financing$10.91M-20.2%-69.1%-97.4%-47.0%
Annual CAPEX$13.39M-73.0%-86.8%-68.7%+256.6%
Annual Free Cash Flow-$6.73M+89.6%+94.5%+17.3%+53.5%
Annual Total Assets$918.64M-4.8%-9.8%+51.6%+1115.0%

Cash From Investing Highs

TXG Annual Cash From Investing Highs Comparison
PeriodHighDateCurrent
3Y$133.49M-124.4%
5Y$133.49M-124.4%
All$133.49M-124.4%

Cash From Investing Lows

TXG Annual Cash From Investing Lows Comparison
PeriodLowDateCurrent
3Y-$350.89MN/A+90.7%
5Y-$350.89M+90.7%
All-$350.89M+90.7%

Cash From Investing History

YearValueChange
-$32.63M-124.4%
$133.49M+138.0%
-$350.89M-228.8%
-$106.73M-178.0%
YearValueChange
-$38.39M+10.2%
-$42.77M-537.5%
-$6.71M-78.6%
-$3.76M-

FAQ

  • What is the current annual cash from investing of TXG?

    As of today, TXG annual cash from investing is -$32.63M

  • What is 1-year change in TXG annual cash from investing?

    TXG annual cash from investing is down -124.44% year-over-year

  • What is 3-year change in TXG annual cash from investing?

    TXG annual cash from investing is up +69.43% over the past 3 years

  • How far is TXG annual cash from investing from its all-time high?

    TXG annual cash from investing is currently -124.44% below its historical high of $133.49M set on December 31, 2023

  • How does TXG annual cash from investing rank versus sector peers?

    TXG annual cash from investing is higher than 26.61% of companies in Healthcare sector

  • When is TXG next annual earnings release?

    The next annual earnings release for TXG is on

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

Data Sources & References

  1. TXG Official Website www.10xgenomics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
  4. TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
  5. TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg